Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

about

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

Item

http://www.wikidata.org/entity/Q47724046

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@en

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@nl

type

Item

label

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@en

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@nl

prefLabel

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@en

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.

@nl

P1476

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy

@en

P2093

Hai Yuan

http://www.w3.org/2001/XMLSchema#string

Hui-Qin Xu

http://www.w3.org/2001/XMLSchema#string

Rong-Yuan Zheng

http://www.w3.org/2001/XMLSchema#string

Wen-Ke Hong

http://www.w3.org/2001/XMLSchema#string

Xian-Chao Chang

http://www.w3.org/2001/XMLSchema#string

Yi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Eslicarbazepine acetate add-on for drug-resistant partial epilepsy

The epidemiology of epilepsy revisited.

Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I.

Eslicarbazepine acetate (BIA 2-093).

Clinical utility of eslicarbazepine: current evidence.

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.

Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies

Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs.

P304

CD008907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/14651858.CD008907.PUB3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067682

http://www.w3.org/2001/XMLSchema#string

P932

6485774

http://www.w3.org/2001/XMLSchema#string